Physician
UCLA Radiology Medical Group
UCLA Radiology Medical Group was paid $11.44M by Medicaid between Jan 2018 and Dec 2024, across 118 billing codes. Its largest line is 70553, Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences — 12% of everything it billed.
33Billing provider infoUCLA RADIOLOGY MEDICAL GROUP
LOS ANGELES, CA 90095
LOS ANGELES, CA 90095
33aNPI1881670248assigned 12/19/2005
33bProvider typeBody Imaging Physician
28Total paid$11.44M
24GClaims422,810
24DCodes billed118
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Body Imaging Physician providers in California
Rank by total paid#1 of 66
Median peer was paid$3K
This provider vs. median3,316×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,085 | $653K | |
| 2019 | 43,075 | $746K | |
| 2020 | 51,728 | $1.08M | |
| 2021 | 65,079 | $1.59M | |
| 2022 | 61,831 | $1.86M | |
| 2023 | 77,853 | $2.74M | |
| 2024incomplete | 79,159 | $2.78M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 12% | 10,306 | 8,838 | $1.34M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11% | 16,066 | 15,003 | $1.23M |
| 71045 | Radiologic examination, chest; single view | 10% | 172,796 | 107,798 | $1.16M |
| 78815 | Positron emission tomography (PET) for limited area imaging | 9.4% | 1,025 | 980 | $1.07M |
| 70450 | Computed tomography, head or brain; without contrast material | 7.6% | 32,415 | 28,209 | $871K |
| 74183 | 4.6% | 3,093 | 3,022 | $523K | |
| 71250 | 3.8% | 9,444 | 9,002 | $436K | |
| 74178 | 3.6% | 3,342 | 3,245 | $411K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3.3% | 7,295 | 7,025 | $373K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.5% | 5,037 | 4,686 | $281K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2.2% | 3,788 | 3,623 | $253K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2.2% | 3,347 | 3,084 | $253K |
106 more codes
| 71046 | Radiologic examination, chest; 2 views | 2.1% | 27,040 | $243K |
| 74018 | 1.7% | 25,700 | $190K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1.4% | 836 | $161K |
| 72197 | 1.4% | 770 | $161K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.2% | 3,537 | $134K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1.2% | 1,497 | $133K |
| 93970 | 1.1% | 2,546 | $123K | |
| 76770 | <1% | 3,501 | $109K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 746 | $98K |
| 72141 | <1% | 870 | $85K | |
| A9581 | Injection, gadoxetate disodium, 1 ml | <1% | 774 | $84K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,378 | $84K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 6,592 | $83K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,373 | $82K |
| 76642 | <1% | 1,496 | $71K | |
| 99152 | <1% | 2,900 | $71K | |
| 74174 | <1% | 748 | $69K | |
| 70491 | <1% | 1,428 | $65K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,874 | $64K |
| 70486 | <1% | 1,051 | $62K | |
| 70496 | <1% | 778 | $53K | |
| 93971 | <1% | 2,141 | $47K | |
| 93976 | <1% | 834 | $47K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 8,182 | $46K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,147 | $45K |
| 49083 | <1% | 409 | $45K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,012 | $43K |
| 76536 | <1% | 1,289 | $43K | |
| 70498 | <1% | 693 | $42K | |
| 75574 | <1% | 220 | $38K | |
| 77065 | Tomosynthesis, mammo | <1% | 492 | $35K |
| 73030 | <1% | 4,064 | $35K | |
| 73221 | <1% | 241 | $31K | |
| 73562 | <1% | 3,744 | $30K | |
| 73130 | <1% | 3,180 | $28K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,129 | $27K |
| 73630 | <1% | 3,069 | $26K | |
| 99223 | Prolong inpt eval add15 m | <1% | 332 | $25K |
| 72110 | <1% | 1,214 | $24K | |
| 73502 | <1% | 2,620 | $23K | |
| 77066 | Tomosynthesis, mammo | <1% | 192 | $21K |
| 93880 | <1% | 308 | $21K | |
| 73610 | <1% | 2,203 | $20K | |
| 72100 | <1% | 1,411 | $16K | |
| 36558 | <1% | 146 | $15K | |
| 73564 | <1% | 1,549 | $14K | |
| 73110 | <1% | 1,753 | $14K | |
| 76937 | <1% | 1,438 | $14K | |
| 72156 | <1% | 80 | $14K | |
| 72158 | <1% | 104 | $13K | |
| 76776 | <1% | 617 | $13K | |
| 77001 | <1% | 692 | $12K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 295 | $11K |
| 76377 | <1% | 464 | $10K | |
| 73590 | <1% | 1,370 | $9K | |
| 73560 | <1% | 1,790 | $9K | |
| 76882 | <1% | 454 | $8K | |
| 73523 | <1% | 415 | $8K | |
| 72050 | <1% | 343 | $8K | |
| 73552 | <1% | 1,034 | $6K | |
| 72157 | <1% | 39 | $6K | |
| 71010 | <1% | 809 | $6K | |
| 73700 | <1% | 125 | $5K | |
| 73718 | <1% | 52 | $5K | |
| 72146 | <1% | 51 | $5K | |
| 93975 | <1% | 46 | $5K | |
| 72040 | <1% | 308 | $4K | |
| 70545 | <1% | 68 | $4K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 81 | $4K |
| G9638 | Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | <1% | 5,901 | $3K |
| 76942 | <1% | 163 | $3K | |
| 76506 | <1% | 145 | $3K | |
| 70548 | <1% | 54 | $3K | |
| 72070 | <1% | 230 | $3K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 45 | $2K |
| 70543 | <1% | 14 | $2K | |
| 77012 | <1% | 27 | $2K | |
| 93925 | <1% | 38 | $2K | |
| 74170 | <1% | 20 | $1K | |
| 71271 | <1% | 45 | $1K | |
| 70544 | <1% | 38 | $1K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 41 | $1K |
| 73080 | <1% | 112 | $1K | |
| 77080 | <1% | 130 | $1K | |
| 70547 | <1% | 24 | $1K | |
| 76604 | <1% | 31 | $988.79 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $940.29 |
| 73090 | <1% | 112 | $940.01 | |
| 72131 | <1% | 13 | $875.34 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $869.98 |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 25 | $827.14 |
| 74000 | <1% | 91 | $496.80 | |
| 72170 | <1% | 106 | $454.73 | |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | <1% | 1,828 | $434.33 |
| 73060 | <1% | 46 | $335.41 | |
| 73070 | <1% | 50 | $306.84 | |
| 50200 | <1% | 12 | $278.79 | |
| 74019 | <1% | 23 | $272.73 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 15 | $131.17 |
| 77073 | <1% | 15 | $80.19 | |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | <1% | 1,599 | $70.45 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $21.19 |
| G9547 | Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols | <1% | 29 | $0.03 |
| 3100F | 0% | 31 | $0.00 | |
| G9550 | Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up | 0% | 13 | $0.00 |
| 3342F | 0% | 70 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialENZMANN, DIETER (DEPARTMENT CHAIRMAN)